Douglas J. Norman

5.5k total citations · 1 hit paper
124 papers, 4.0k citations indexed

About

Douglas J. Norman is a scholar working on Transplantation, Surgery and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Douglas J. Norman has authored 124 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Transplantation, 52 papers in Surgery and 29 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Douglas J. Norman's work include Renal Transplantation Outcomes and Treatments (73 papers), Organ Transplantation Techniques and Outcomes (34 papers) and Organ Donation and Transplantation (26 papers). Douglas J. Norman is often cited by papers focused on Renal Transplantation Outcomes and Treatments (73 papers), Organ Transplantation Techniques and Outcomes (34 papers) and Organ Donation and Transplantation (26 papers). Douglas J. Norman collaborates with scholars based in United States, Canada and Germany. Douglas J. Norman's co-authors include William M. Bennett, John M. Barry, Charles F. Shield, Angelo M. de Mattos, Michael R. Keating, Jonathan C. Prather, Adam Crisp, Patrick J. Brennan, R. Méndez and Josef Kovařík and has published in prestigious journals such as New England Journal of Medicine, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Douglas J. Norman

122 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal Transplantation

1999 536 citations Douglas J. Norman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Douglas J. Norman United States	36	1.8k	1.3k	924	643	555	124	4.0k
B Charpentier France	30	1.8k 1.0×	1.1k 0.9×	709 0.8×	855 1.3×	638 1.1×	204	3.8k
Arnold G. Diethelm United States	35	1.4k 0.8×	1.2k 0.9×	770 0.8×	428 0.7×	539 1.0×	127	3.9k
David Taube United Kingdom	38	1.7k 0.9×	1.3k 1.0×	494 0.5×	558 0.9×	447 0.8×	151	4.5k
J.M. Morales Spain	35	2.0k 1.1×	1.1k 0.9×	892 1.0×	185 0.3×	511 0.9×	154	3.9k
Ronald H. Kerman United States	30	1.9k 1.0×	1.4k 1.1×	398 0.4×	581 0.9×	553 1.0×	131	3.3k
Ronald M. Ferguson United States	47	3.1k 1.7×	2.4k 1.9×	1.1k 1.2×	923 1.4×	933 1.7×	149	6.0k
Ronald J. Hené Netherlands	32	1.5k 0.8×	1.0k 0.8×	363 0.4×	428 0.7×	477 0.9×	92	3.5k
Anke Schwarz Germany	39	1.8k 1.0×	1.5k 1.2×	623 0.7×	481 0.7×	619 1.1×	154	5.6k
Gunnar Tydén Sweden	38	3.0k 1.6×	2.5k 1.9×	572 0.6×	432 0.7×	867 1.6×	187	4.8k
Winfred W. Williams United States	27	2.5k 1.3×	1.5k 1.2×	533 0.6×	998 1.6×	478 0.9×	64	4.0k

Countries citing papers authored by Douglas J. Norman

Since Specialization

Citations

This map shows the geographic impact of Douglas J. Norman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas J. Norman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas J. Norman more than expected).

Fields of papers citing papers by Douglas J. Norman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas J. Norman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas J. Norman. The network helps show where Douglas J. Norman may publish in the future.

Co-authorship network of co-authors of Douglas J. Norman

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas J. Norman. A scholar is included among the top collaborators of Douglas J. Norman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas J. Norman. Douglas J. Norman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rehman, Shehzad, et al.. (2023). Sustained Response to Eculizumab in a Patient With COVID-19–Associated Acute Thrombotic Microangiopathy of the Allograft Kidney: A Case Report. Transplantation Proceedings. 55(8). 1866–1869. 1 indexed citations

Chandraker, Anil, Kenneth A. Andreoni, Robert S. Gaston, et al.. (2019). Time for reform in transplant program–specific reporting: AST/ASTS transplant metrics taskforce. American Journal of Transplantation. 19(7). 1888–1895. 37 indexed citations

Troxell, Megan L., D. Bradley Koslin, Douglas J. Norman, Stephen C. Rayhill, & Anuja Mittalhenkle. (2010). Pancreas Allograft Rejection: Analysis of Concurrent Renal Allograft Biopsies and Posttherapy Follow-Up Biopsies. Transplantation. 90(1). 75–84. 34 indexed citations

Norman, Douglas J.. (2006). Kidney paired donation: a single-center study of feasibility and outcomes. Nature Clinical Practice Nephrology. 2(6). 302–303. 1 indexed citations

Wynn, J. D., Dale A. Distant, John D. Pirsch, et al.. (2004). Kidney and pancreas transplantation. American Journal of Transplantation. 4. 72–80. 95 indexed citations

Norman, Douglas J., et al.. (2001). Use of A2 kidneys for B and O kidney transplant recipients: report of a series of patients transplanted at a single center spanning a decade. Transplantation Proceedings. 33(7-8). 3327–3330. 5 indexed citations

Norman, Douglas J., Flavio Vincenti, Angelo M. de Mattos, et al.. (2000). PHASE I TRIAL OF HuM291, A HUMANIZED ANTI-CD3 ANTIBODY, IN PATIENTS RECEIVING RENAL ALLOGRAFTS FROM LIVING DONORS1. Transplantation. 70(12). 1707–1712. 42 indexed citations

Alkhunaizi, Ahmed M., Angelo M. de Mattos, John M. Barry, William M. Bennett, & Douglas J. Norman. (1999). RENAL TRANSPLANTATION ACROSS THE ABO BARRIER USING A2 KIDNEYS. Transplantation. 67(10). 1319–1324. 77 indexed citations

Alkhunaizi, Ahmed M., Ali J. Olyaei, John M. Barry, et al.. (1998). EFFICACY AND SAFETY OF LOW MOLECULAR WEIGHT HEPARIN IN RENAL TRANSPLANTATION1. Transplantation. 66(4). 533–534. 38 indexed citations

10.

Mattos, Angelo M. de, et al.. (1997). Interleukin-12 p40 m-RNA expression in human kidney allograft biopsies. Transplant Immunology. 5(3). 199–203. 5 indexed citations

11.

Heston, Thomas F, Douglas J. Norman, John M. Barry, William M. Bennett, & Richard A. Wilson. (1997). Cardiac Risk Stratification in Renal Transplantation Using a Form of Artificial Intelligence. The American Journal of Cardiology. 79(4). 415–417. 22 indexed citations

12.

Barry, John M., et al.. (1996). Cadaver kidney transplantation in patients more than 65 years old. World Journal of Urology. 14(4). 243–8. 9 indexed citations

13.

Ott, Gary Y., et al.. (1994). Cardiac allografts from high-risk donors: Excellent clinical results. The Annals of Thoracic Surgery. 57(1). 76–82. 47 indexed citations

14.

Mattos, Angelo M. de, M A Head, Jeffrey D. Hosenpud, et al.. (1994). HLA-DR MISMATCHING CORRELATES WITH EARLY CARDIAC ALLOGRAFT REJECTION, INCIDENCE, AND GRAFT SURVIVAL WHEN HIGH-CONFIDENCE-LEVEL SEROLOGICAL DR TYPING IS USED. Transplantation. 57(4). 626–630. 25 indexed citations

15.

Norman, Douglas J., Lawrence Kahana, Frank P. Stuart, et al.. (1993). A RANDOMIZED CLINICAL TRIAL OF INDUCTION THERAPY WITH OKT3 IN KIDNEY TRANSPLANTATION. Transplantation. 55(1). 44–50. 113 indexed citations

16.

Henell, Karen, A C Bakke, Tara Kenny, et al.. (1991). Degree of modulation of cell-surface CD3 by anti-lymphocyte therapies.. PubMed. 23(1 Pt 2). 1070–1. 10 indexed citations

17.

Goldstein, Gideon, et al.. (1988). PHARMACOKINETIC STUDY OF ORTHOCLONE OKT3 SERUM LEVELS DURING TREATMENT OF ACUTE RENAL ALLOGRAFT REJECTION. Transplantation. 46(4). 587–588. 29 indexed citations

18.

Shield, Charles F., et al.. (1987). Comparison of Antimouse and Antihorse Antibody Production during the Treatment of Allograft Rejection with OKT3 or Antithymocyte Globulin. The Nephron journals/Nephron journals. 46(1). 48–51. 21 indexed citations

19.

Norman, Douglas J., John M. Barry, & Susan M. Fischer. (1986). THE BENEFICIAL EFFECT OF PRETRANSPLANT THIRD-PARTY BLOOD TRANSFUSIONS ON ALLOGRAFT REJECTION IN HLA-IDENTICAL SIBLING KIDNEY TRANSPLANTS. Transplantation. 41(1). 125–125. 4 indexed citations

20.

Barry, John M., Douglas J. Norman, & William M. Bennett. (1985). Pediatric Cadaver Kidney Transplants into Adults. The Journal of Urology. 134(4). 651–652. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact